Liu, YanshanBanka, SiddharthHuang, YingzhiHardman-Smart, JonathanPye, DerekTorrelo, AntonioBeaman, Glenda MKazanietz, Marcelo GBaker, Martin JFerrazzano, CarloShi, ChenfuOrozco, GiselaEyre, Stephenvan Geel, MichelBygum, AnetteFischer, JudithMiedzybrodzka, ZosiaAbuzahra, FarisRübben, AlbertCuvertino, SaraEllingford, Jamie MSmith, Miriam JEvans, D GarethWeppner-Parren, Lizelotte J M Tvan Steensel, Maurice A MChaudhary, Iskander HMangham, D ChasLear, John TPaus, RalfFrank, JorgeNewman, William GZhang, Xue2023-09-112023-09-112022-12-04Liu, Y, Banka, S, Huang, Y, Hardman-Smart, J, Pye, D, Torrelo, A, Beaman, G M, Kazanietz, M G, Baker, M J, Ferrazzano, C, Shi, C, Orozco, G, Eyre, S, van Geel, M, Bygum, A, Fischer, J, Miedzybrodzka, Z, Abuzahra, F, Rübben, A, Cuvertino, S, Ellingford, J M, Smith, M J, Evans, D G, Weppner-Parren, L J M T, van Steensel, M A M, Chaudhary, I H, Mangham, D C, Lear, J T, Paus, R, Frank, J, Newman, W G & Zhang, X 2022, 'Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome', British Journal of Dermatology, vol. 187, no. 6, pp. 948-961. https://doi.org/10.1111/bjd.218420007-0963Bibtex: https://doi.org/10.1111/bjd.21842ORCID: /0000-0003-2890-8136/work/175113377https://hdl.handle.net/2164/21645Funding sources X.Z. is supported by the National Natural Science Foundation of China (grant number 81788101), the CAMS Innovation Fund for Medical Sciences (grant numbers 2021-I2M-1-018 and 2016-I2M-1-002) and the National Key Research and Development Program of China (grant number 2016YFC0905100). M.J.S., D.G.E., R.P. and W.G.N. are supported by the Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007). Z.M. is supported by the NHS Grampian Biorepository (NHS Scotland). J.M.E. is funded by a postdoctoral research fellowship from the Health Education England Genomics Education Programme. G.O. and C.S. are funded by Wellcome Trust awards (207491/Z/17/Z for G.O., 215207/Z/19/Z for C.S.). G.O., C.S. and S.E. are supported by a Versus Arthritis award (21754) and NIHR Manchester BRC. S.E. is supported by a Medical Research Council award (MR/N00017X/1).1517542536engR MedicineNational Institute for Health Research (NIHR)IS-BRC-1215-20007Wellcome Trust207491/Z/17/Z215207/Z/19/ZOtherMR/N00017X/1Medical Research Council (MRC)MR/N00017X/1Supplementary InformationRGermline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndromeJournal article10.1111/bjd.218421876